EH301 (Nicotinamide Riboside/Pterostilbene)
Sponsors
Haukeland University Hospital
Conditions
Amyotrophic Lateral Sclerosis
Unknown Phase
The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.
Active, not recruitingNCT04562831
Start: 2020-10-07End: 2026-10-31Target: 380Updated: 2026-01-12
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
RecruitingNCT05095571
Start: 2021-10-07End: 2026-12-31Target: 300Updated: 2025-03-19